Exoskeleton company ReWalk Robotics Ltd. is planning to raise $40m in a private placement to fund commercialization of its rehabilitation and mobility aids.
The Israel-based company announced on 19 February it entered into a securities purchase agreements with certain institutional and other accredited investors to raise $40m through the issuance of 10,921,502 ordinary shares and warrants to buy up to 5,460,751 ordinary shares at a purchase price of $3
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?